1.75
price down icon0.57%   -0.01
 
loading

Celularity Inc Aktie (CELU) Neueste Nachrichten

pulisher
03:27 AM

Two Sigma Investments LP Invests $93,000 in Celularity Inc. (NASDAQ:CELU) - Defense World

03:27 AM
pulisher
Jun 12, 2025

Celularity (NASDAQ:CELU) Shares Down 10.4% – Here’s Why - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

# Celularity terminates CFO, appoints interim replacement By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity stock falls after CFO David Beers terminated By Investing.com - Investing.com Nigeria

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity stock falls after CFO David Beers terminated - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity (CELU) Appoints Interim CFO After Terminating Current CFO | CELU Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity Names Joseph DosSantos Interim CFO - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity Announces Chief Financial Officer Transition - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

# Celularity terminates CFO, appoints interim replacement - Investing.com

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity terminates CFO David Beers - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Celularity Announces Sudden CFO Departure, Taps Internal Talent and External Advisory Firm - Stock Titan

Jun 10, 2025
pulisher
Jun 03, 2025

Celularity announces publication on advancing ocular surface reconstruction - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Celularity (CELU) Advances Stem Cell Research with Innovative Bi - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Revolutionary Stem Cell Breakthrough: New Technology Could Transform Eye Disease Treatment - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

Celularity Receives Nasdaq Notice Regarding Form 10-Q - The Manila Times

May 31, 2025
pulisher
May 30, 2025

Celularity Inc. Notified by Nasdaq of Non-Compliance with Quarterly Filing Requirements - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Celularity Gets 60 Days to Fix Nasdaq Compliance After Missing Q1 Filing Deadline - Stock Titan

May 30, 2025
pulisher
May 22, 2025

Reklaim Ltd. Reports Record 73% Revenue Growth in Q1 2025 and Launches Subscription Privacy Service - The Globe and Mail

May 22, 2025
pulisher
May 21, 2025

Celularity (NASDAQ:CELU) Trading 7.4% Higher – Here’s Why - Defense World

May 21, 2025
pulisher
May 20, 2025

Celularity extends debt maturity, issues stock to YA II PN By Investing.com - Investing.com India

May 20, 2025
pulisher
May 20, 2025

Celularity extends debt maturity, issues stock to YA II PN - Investing.com Australia

May 20, 2025
pulisher
May 20, 2025

Celularity Extends Note Maturity with YA II PN - TipRanks

May 20, 2025
pulisher
May 14, 2025

Celularity Inc. Advances Placental-Derived Therapies - TipRanks

May 14, 2025
pulisher
May 09, 2025

Celularity (CELU) Reports Significant Revenue Growth in FY24 | C - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Celularity Announces Full Year 2024 Operating and Financial Results - The Manila Times

May 09, 2025
pulisher
May 09, 2025

Celularity Inc. Reports Strong Financial Growth and Increased Revenue for Year Ended December 31, 2024 - Nasdaq

May 09, 2025
pulisher
May 08, 2025

Celularity Inc SEC 10-K Report - TradingView

May 08, 2025
pulisher
May 02, 2025

Nvidia (NVDA) Targets Trillion Dollar Opportunity as Trump Ponders Lifting AI Chip Curbs - The Globe and Mail

May 02, 2025
pulisher
Apr 30, 2025

Should You Buy PayPal Stock on the Dip in May 2025? - The Globe and Mail

Apr 30, 2025
pulisher
Apr 29, 2025

The end of La Niña: Lessons about Plains wheat drought & why spring weather is bearish for most grain markets - The Globe and Mail

Apr 29, 2025
pulisher
Apr 28, 2025

Earnings To Watch: Caesars Entertainment (CZR) Reports Q1 Results Tomorrow - The Globe and Mail

Apr 28, 2025
pulisher
Apr 26, 2025

Celularity (CELU) Resolves Nasdaq Fee Issue to Avoid Delisting | - GuruFocus

Apr 26, 2025
pulisher
Apr 26, 2025

Celularity (NASDAQ:CELU) Stock Price Down 4.7% – Time to Sell? - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Celularity pays $70,000 fee to Nasdaq following receipt of notice - MSN

Apr 26, 2025
pulisher
Apr 26, 2025

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees - The Manila Times

Apr 26, 2025
pulisher
Apr 25, 2025

Celularity Inc. Faces Potential Delisting from Nasdaq Due to Fee and Filing Delinquencies - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

Celularity Given Until May 1 to Address Dual Nasdaq Compliance Issues or Face Delisting - Stock Titan

Apr 25, 2025
pulisher
Apr 24, 2025

Celularity faces Nasdaq delisting over late filing By Investing.com - Investing.com India

Apr 24, 2025
pulisher
Apr 23, 2025

Celularity faces Nasdaq delisting over late filing - Investing.com

Apr 23, 2025
pulisher
Apr 17, 2025

Looking for Exposure to Nvidia Stock? Try These Two ETFs - The Globe and Mail

Apr 17, 2025
pulisher
Apr 15, 2025

Markel Group to give a presentation at the beginning of its annual Omaha Brunch - The Globe and Mail

Apr 15, 2025
pulisher
Apr 14, 2025

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

CMS Extends Medicare Coverage for Wound Care Products: Major Win for Skin Substitute Market - Stock Titan

Apr 14, 2025
pulisher
Apr 07, 2025

Revolutionary NK Cell Therapy Shows Promise in Cancer Treatment: New Research Reveals - Stock Titan

Apr 07, 2025
pulisher
Apr 04, 2025

Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology - The Globe and Mail

Apr 04, 2025
$98.73
price up icon 1.91%
$22.82
price down icon 1.17%
$34.84
price down icon 1.22%
$19.78
price down icon 1.88%
$106.57
price up icon 1.57%
biotechnology ONC
$269.63
price down icon 2.50%
Kapitalisierung:     |  Volumen (24h):